Comparison of kidney allograft survival in the Eurotransplant senior program after changing the allocation criteria in 2010—A single center experience

Aims: The European Senior Program (ESP) aims to avoid waiting list competition between younger and elderly patients applying for renal transplantation. By listing patients ≥65 years on a separate waiting list and locally allocating of grafts ≥65 years exclusively to this cohort, waiting and cold isc...

Verfasser: Mehdorn, Anne-Sophie
Reuter, Stefan Johannes
Suwelack, Barbara
Schütte-Nütgen, Katharina
Becker, Felix
Senninger, Norbert
Palmes, Daniel Michael
Vogel, Thomas
Bahde, Ralf
FB/Einrichtung:FB 05: Medizinische Fakultät
Dokumenttypen:Artikel
Medientypen:Text
Erscheinungsdatum:2020
Publikation in MIAMI:04.04.2022
Datum der letzten Änderung:04.04.2022
Angaben zur Ausgabe:[Electronic ed.]
Quelle:PLoS ONE 15 (2020) 7, e0235680, 1-16
Schlagwörter:Graft survival; Medical dialysis; Renal transplantation; Creatinine; Diabetes mellitus; Ischemia; Surgical and invasive medical procedures; Geriatric care
Fachgebiet (DDC):610: Medizin und Gesundheit
Lizenz:CC BY 4.0
Sprache:Englisch
Förderung:Finanziert durch den Open-Access-Publikationsfonds der Westfälischen Wilhelms-Universität Münster (WWU Münster).
Format:PDF-Dokument
URN:urn:nbn:de:hbz:6-24049617350
Weitere Identifikatoren:DOI: 10.17879/24049618455
Permalink:https://nbn-resolving.de/urn:nbn:de:hbz:6-24049617350
Verwandte Dokumente:
Onlinezugriff:10.1371_journal.pone.0235680.pdf

Aims: The European Senior Program (ESP) aims to avoid waiting list competition between younger and elderly patients applying for renal transplantation. By listing patients ≥65 years on a separate waiting list and locally allocating of grafts ≥65 years exclusively to this cohort, waiting and cold ischemia times are predicted to be shortened, potentially resulting in improved kidney transplantation outcomes. This study compared a historic cohort of renal transplant recipients being simultaneously listed on the general and the ESP waiting lists with a collective exclusively listed on the ESP list in terms of surrogates of the transplantation outcome. Methods: Total 151 eligible patients ≥ 65 years from Münster transplant Center, Germany, between 1999 and 2014 were included. Graft function, graft and patient survival were compared using surrogate markers of short- and long-term graft function. Patients were grouped according to their time of transplantation. Results: Recipients and donors in the newESP (nESP) cohort were significantly older (69.6 ± 3.5 years vs 67.1 ± 2 years, p